Eduardo Sagredo
Affiliations: | Universidad de Chile, Santiago, Región Metropolitana, Chile |
Google:
"Eduardo Sagredo"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bernal YA, Durán E, Solar I, et al. (2024) ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer. International Journal of Molecular Sciences. 25 |
| Bernal YA, Blanco A, Sagredo EA, et al. (2024) A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer. Biomedicines. 12 |
| Morales F, Pérez P, Tapia JC, et al. (2022) Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells. Gene. 819: 146246 |
| Dufey E, Bravo-San Pedro JM, Eggers C, et al. (2020) Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response. Nature Communications. 11: 2401 |
| Sagredo EA, Sagredo AI, Blanco A, et al. (2020) ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response. Biochimica Et Biophysica Acta. Molecular Cell Research. 118716 |
| Cappelli C, Sepulveda H, Rivas S, et al. (2020) Ski Is Required for Tri-Methylation of H3K9 in Major Satellite and for Repression of Pericentromeric Genes: Mmp3, Mmp10 and Mmp13, in Mouse Fibroblasts. Journal of Molecular Biology |
| Sagredo AI, Sagredo EA, Pola V, et al. (2018) TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines. Journal of Cellular Physiology |
| Sagredo EA, Blanco A, Sagredo AI, et al. (2018) ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biological Research. 51: 36 |
| Sagredo AI, Sagredo EA, Cappelli C, et al. (2017) TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells. Molecular Oncology |